Form 4 Tracker
Solid Biosciences Inc.
SLDB

41 insider filings · Latest: Oct 2, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 4, 2026Feb 6 10:56 PMPaul HerzichChief Technology Officer
Sale
10,905$6.44$70.2K69,067(D)

View →

Feb 4, 2026Feb 5 12:48 AMTan Kevin
Proposed Sale
14,783$6.44$95.2K—

View →

Feb 4, 2026Feb 5 12:46 AMHerzich Paul
Proposed Sale
10,905$6.44$70.2K—

View →

Feb 4, 2026Feb 5 12:45 AMGanot Ilan
Proposed Sale
7,205$6.44$46.4K—

View →

Feb 4, 2026Feb 5 12:44 AMCumbo Alexander
Proposed Sale
48,913$6.44$315.1K—

View →

Feb 4, 2026Feb 5 12:42 AMHowton David T
Proposed Sale
18,894$6.44$121.7K—

View →

Feb 4, 2026Feb 5 12:40 AMHanrahan Jessie
Proposed Sale
12,348$6.44$79.5K—

View →

Feb 4, 2026Feb 5 12:37 AMBrooks Gabriel
Proposed Sale
12,616$6.44$81.3K—

View →

Feb 2, 2026Feb 3 1:18 AMKevin TanCFO & Treasurer
Sale
26,837$6.44$172.7K108,984(D)

View →

Feb 2, 2026Feb 3 1:16 AMAlexander CumboDirector, President and CEO
Sale
80,258$6.44$516.6K270,931(D)

View →

Feb 2, 2026Feb 3 1:15 AMJessie HanrahanChief Regulatory Officer
Sale
26,535$6.44$170.8K82,675(D)

View →

Feb 2, 2026Feb 3 1:14 AMGabriel BrooksChief Medical Officer
Sale
28,335$6.44$182.4K96,708(D)

View →

Feb 2, 2026Feb 3 1:12 AMDavid T HowtonChief Operating Officer
Sale
37,771$6.44$243.1K116,753(D)

View →

Feb 2, 2026Feb 3 1:09 AMPaul HerzichChief Technology Officer
Sale
26,250$6.44$169.0K79,972(D)

View →

Feb 2, 2026Feb 3 1:07 AMHanrahan Jessie
Proposed Sale
26,535$6.44$170.8K—

View →

Feb 2, 2026Feb 3 1:05 AMBrooks Gabriel
Proposed Sale
28,335$6.44$182.4K—

View →

Feb 2, 2026Feb 3 1:04 AMTan Kevin
Proposed Sale
26,837$6.44$172.7K—

View →

Feb 2, 2026Feb 3 1:03 AMCumbo Alexander
Proposed Sale
80,258$6.44$516.6K—

View →

Feb 2, 2026Feb 3 1:01 AMHowton David T
Proposed Sale
37,771$6.44$243.1K—

View →

Feb 2, 2026Feb 3 12:59 AMHerzich Paul
Proposed Sale
26,250$6.44$169.0K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 2, 2026Oct 6 8:35 PMIan F SmithDirector
Option Exercise
3,440—3,440(D)

View →

Jul 2, 2026Jul 7 8:05 PMIan F SmithDirector
Option Exercise
3,440—6,880(D)

View →

Jun 10, 2026Jun 11 8:05 PMSukumar NagendranDirector
Grant/Award
77,500$6.6177,500(D)

View →

Jun 10, 2026Jun 11 8:05 PMIan F SmithDirector
Grant/Award
77,500$6.6177,500(D)

View →

Jun 10, 2026Jun 11 8:05 PMIlan GanotDirector
Grant/Award
77,500$6.6177,500(D)

View →

Jun 10, 2026Jun 11 8:05 PMPERCEPTIVE ADVISORS LLCDirector, 10% Owner
Grant/Award
77,500$6.6177,500(I)

View →

Jun 10, 2026Jun 11 8:05 PMGeorgia KerestyDirector
Grant/Award
77,500$6.6177,500(D)

View →

Jun 10, 2026Jun 11 8:05 PMMartin I FreedDirector
Grant/Award
77,500$6.6177,500(D)

View →

Jun 10, 2026Jun 11 8:05 PMClare KahnDirector
Grant/Award
77,500$6.6177,500(D)

View →

Jun 10, 2026Jun 11 8:05 PMLynne Marie SullivanDirector
Grant/Award
77,500$6.6177,500(D)

View →

Jun 10, 2026Jun 11 8:05 PMAdam Leo StoneDirector
Grant/Award
77,500$6.6177,500(D)

View →

Jan 29, 2026Apr 21 8:05 PMDavid T HowtonChief Operating Officer
Grant/Award
79,341—79,341(D)

View →

Jan 29, 2026Apr 21 8:05 PMGabriel BrooksChief Medical Officer
Grant/Award
58,847—58,847(D)

View →

Jan 29, 2026Apr 21 8:05 PMAlexander CumboDirector, President and CEO
Grant/Award
169,401—169,401(D)

View →

Jan 29, 2026Apr 21 8:05 PMPaul HerzichChief Technology Officer
Grant/Award
54,925—54,925(D)

View →

Jan 29, 2026Apr 21 8:05 PMKevin TanCFO & Treasurer
Grant/Award
56,647—56,647(D)

View →

Jan 29, 2026Apr 21 8:05 PMJessie HanrahanChief Regulatory Officer
Grant/Award
54,925—54,925(D)

View →

Apr 2, 2026Apr 2 8:05 PMIan F SmithDirector
Option Exercise
3,441—10,320(D)

View →

Mar 9, 2026Mar 11 8:00 PMPERCEPTIVE ADVISORS LLCDirector, 10% Owner
Grant/Award
8,912,655$0.0018,912,655(I)

View →

Feb 13, 2026Feb 19 2:38 AMAlexander CumboDirector, President and CEO
Option Exercise
30,031—60,063(D)

View →

Page 1 of 3

Next →